Compound lights up spreading cancer cells

WASHINGTON (Reuters) - A new type of imaging compound can literally light up spreading cancer cells and may offer a way to track the deadly spread of the disease, Japanese and U.S. researchers reported on Sunday.

They used the new compound to monitor the spread of breast and ovarian cancer cells in living mice, using a tiny camera known as an endoscope.

“These compounds may allow clinicians to monitor a patient’s response to cancer therapy by allowing them to visualize whether a drug hits its target and whether hitting the target leads to shrinkage of the tumor,” Dr. Hisataka Kobayashi of the U.S. National Cancer Institute, who helped lead the study, said in a statement.

Kobayashi and Yasuteru Urano of the University of Tokyo first targeted breast cancer cells with a certain mutation in what is known as the epidermal growth factor receptor or EGFR, which drives several different cancers.

This mutation is targeted by Genentech’s breast cancer drug Herceptin, known generically as trastuzumab.

The researchers made their imaging compound by linking a fluorescent compound to Herceptin, which is itself a genetically engineered antibody that homes in on cells with mutated EGFR.

It only attaches to living cells, making it possible to specifically find living cancer cells.

Sure enough, they could see breast tumors in living mice, and tumor cells after they spread away from the initial tumor site, they reported in the journal Nature Medicine.

Using another cancer drug, Roche AG’s Zenapax, known generically as daclizumab, and an endoscope, they imaged ovarian cancer tumors that had spread inside the abdominal cavity of living mice.

“Our design concept is very versatile and can be used to detect many types of cancer,” said Kobayashi.

“Unlike other activatable fluorescent compounds, our compound consists of a targeting agent and a fluorescing agent that act independently. We can target the fluorescing agent to different types of cancer cells by using any antibody or molecule that is internalized by the targeted cells after it binds to the cell’s surface proteins.”

Half an hour after they killed the cells, the red fluorescent light stopped, they said.

(Reporting by Maggie Fox; editing by Mohammad Zargham)


Related Posts:

By Julie Steenhuysen CHICAGO (Reuters) - A single gene appears to play a crucial role in deadly breast cancers, increasing the chances the cancer will spread and making it resistant to chemotherapy, U.S. researchers said on Monday. They found people with aggressive breast cancers have abnormal genetic alterations in a gene called MTDH, and drugs that block

Full Post: Scientists find a gene that makes cancer spread

WASHINGTON (Reuters) - Little breast tumors that seemed cured after surgery are more likely to come back if they are the type known as HER2 positive, U.S. researchers reported on Friday. They said women who have these types of tumors may need extra treatment with drugs such as Genentech Inc.’s Herceptin — which is not standard

Full Post: Small breast tumors might need more treatment: study

NEW YORK (Reuters Health) - Noscapine, a natural substance found in cough medicine, may prove useful in treating advanced prostate cancer, according to studies in mice. Researchers found that noscapine — a non-addictive derivative of opium — reduced tumor growth in mice by 60 percent and limited the spread of tumors by 65 percent without causing

Full Post: Cough medicine ingredient may treat prostate cancer

LONDON (Reuters) - A technique using a tiny glass window implanted on the skin of a mouse allows scientists to track individual cancer cells as they spread and attack other parts of the body, according to a study published on Sunday. This window could one day play a big role in analyzing how well developmental

Full Post: Glass implant on tumor helps track cancer in mice

LONDON (Reuters) - Genentech and Roche’s cancer drug Avastin can help find tumors as well as treat them, scientists said on Wednesday. After tagging the antibody drug with a radioactive tracer and injecting it into mice, researchers found it successfully targeted cancer cells and this enabled them to produce well-defined images of tumors during scanning. When compared

Full Post: Cancer drug Avastin may work as imaging tool too

Site Navigation

Most Read